Meeting
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Association of immune microenvironment to response in treatment-naïve non-small cell lung cancer (NSCLC) samples with follow-up second-line immunotherapy data.
Authors
Marie Cumberbatch
TriStar Technology Group, LLC, Washington, WA
Marie Cumberbatch, Nathan Elliott, Sarah Warren, Woo Ho Kim, Christopher Womack, Milan Bhagat, Lorenzo Colarossi, Lorenzo Memeo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies
Sub Track
Biomarkers and Inflammatory Signatures
Citation
J Clin Oncol 38, 2020 (suppl 5; abstr 49)
Abstract #
49
Poster Bd #
B10
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Multi-omic and spatial dissection of immunotherapy response groups in non–small cell lung cancer (NSCLC).
First Author: Kenneth John O'Byrne
Poster
2024 ASCO Annual Meeting
Multiplex analysis of the immune environment before and after neoadjuvant durvalumab as a prognostic factor in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase 2 trial.
First Author: Diane Damotte
Poster
2024 ASCO Genitourinary Cancers Symposium
Alterations in tumor immune microenvironment and progressive immune exhaustion with advancing penile squamous cell carcinoma using multiplex immunofluorescence and image analysis.
First Author: Keerthi Gullapalli
Poster
2023 ASCO Annual Meeting
Molecular characterization of resistance to immune checkpoint inhibitor and chemotherapy treatment in advanced non-small cell lung cancer.
First Author: Jordan Kardos